Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 61, Number 11, December 09, 2003
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrade, D. M.
Right arrow Articles by Minassian, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrade, D. M.
Right arrow Articles by Minassian, B. A.
Related Collections
Right arrow Diagnostic test assessment
Right arrow Metabolic disease (inherited)
NEUROLOGY 2003;61:1611-1614
© 2003 American Academy of Neurology


Brief Communications

Skin biopsy in Lafora disease

Genotype–phenotype correlations and diagnostic pitfalls

D. M. Andrade, MD, C. A. Ackerley, PhD, T. S.C. Minett, MD, H. A.G. Teive, MD, S. Bohlega, MD, S. W. Scherer, PhD and B. A. Minassian, MD

From the Program in Genetics and Genomic Biology (Drs. Andrade, Scherer, and Minassian), Research Institute, and Division of Neurology (Dr. Minassian), Departments of Paediatrics and Genetics, Department of Pathology (Dr. Ackerley), Hospital for Sick Children and University of Toronto, and Department of Molecular and Medical Genetics (Dr. Andrade), University of Toronto, Ontario, Canada; Division of Behavioral Neurology (Dr. Minett), Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, Escola Paulista de Medicina, and Movement Disorder Unit (Dr. Teive), Neurology Service, Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil; and Department of Neurosciences (Dr. Bohlega), King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Address correspondence and reprint requests to Dr. B.A. Minassian, Division of Neurology, Departments of Paediatrics and Genetics, Hospital for Sick Children and University of Toronto, 555 University Ave., Toronto, Ontario, Canada M5G 1X8; e-mail: bminass{at}sickkids.ca

Lafora disease is characterized by pathognomonic inclusions, Lafora bodies (LB), in neurons and other cell types. In skin, LB have been reported in either eccrine sweat glands or in apocrine sweat glands. The disease is caused by mutations in either the EPM2A gene or in a second yet-unknown gene. Here the authors determine whether a genotype–phenotype correlation exists between the genetic form of the disease and the skin cell type affected by LB formation. Also is described an important source of false positivity in the use of axillary biopsies for disease diagnosis.


Received June 27, 2003. Accepted in final form August 5, 2003.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the December 9 issue to find the title link for this article.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
M. C. Solaz-Fuster, J. V. Gimeno-Alcaniz, S. Ros, M. E. Fernandez-Sanchez, B. Garcia-Fojeda, O. C. Garcia, D. Vilchez, J. Dominguez, M. Garcia-Rocha, M. Sanchez-Piris, et al.
Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway
Hum. Mol. Genet., March 1, 2008; 17(5): 667 - 678.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
J. Turnbull, S. Kumar, Z.-P. Ren, S. Muralitharan, T. Naranian, C. A. Ackerley, and B. A. Minassian
Lafora Progressive Myoclonus Epilepsy: Disease Course Homogeneity in a Genetic Isolate
J Child Neurol, February 1, 2008; 23(2): 240 - 242.
[Abstract] [PDF]


Home page
NeurologyHome page
H. Lohi, J. Turnbull, X. C. Zhao, S. Pullenayegum, L. Ianzano, M. Yahyaoui, M. A. Mikati, N. P. Quinn, S. Franceschetti, F. Zara, et al.
Genetic diagnosis in Lafora disease: Genotype-phenotype correlations and diagnostic pitfalls
Neurology, March 27, 2007; 68(13): 996 - 1001.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.